155 related articles for article (PubMed ID: 38773448)
21. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling.
Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G
J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807
[TBL] [Abstract][Full Text] [Related]
22. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma.
Yen CJ; Lin YJ; Yen CS; Tsai HW; Tsai TF; Chang KY; Huang WC; Lin PW; Chiang CW; Chang TT
PLoS One; 2012; 7(7):e41931. PubMed ID: 22848663
[TBL] [Abstract][Full Text] [Related]
24. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies.
Petrick JL; Florio AA; Koshiol J; Pfeiffer RM; Yang B; Yu K; Chen CJ; Yang HI; Lee MH; McGlynn KA
Int J Cancer; 2020 Nov; 147(10):2743-2753. PubMed ID: 32406072
[TBL] [Abstract][Full Text] [Related]
25. Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Teng CF; Wu HC; Shyu WC; Jeng LB; Su IJ
Cell Transplant; 2017 Mar; 26(3):429-438. PubMed ID: 28195035
[TBL] [Abstract][Full Text] [Related]
26. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics.
Wang Y; Wang S; Che Y; Chen D; Liu Y; Shi Y
Medicine (Baltimore); 2021 Aug; 100(33):e26917. PubMed ID: 34414947
[TBL] [Abstract][Full Text] [Related]
27. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
[TBL] [Abstract][Full Text] [Related]
28. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
29. Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis.
Teng CF; Wu HC; Hsieh WC; Tsai HW; Su IJ
J Virol; 2015 Jan; 89(1):605-14. PubMed ID: 25339766
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma.
Yen CH; Lu YC; Li CH; Lee CM; Chen CY; Cheng MY; Huang SF; Chen KF; Cheng AL; Liao LY; Lee YH; Chen YM
Mol Med; 2012 Mar; 18(1):286-96. PubMed ID: 22160218
[TBL] [Abstract][Full Text] [Related]
31. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
32. Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling.
Chen T; Yuan Z; Lei Z; Duan J; Xue J; Lu T; Yan G; Zhang L; Liu Y; Li Q; Zhang Y
Theranostics; 2022; 12(17):7450-7464. PubMed ID: 36438486
[No Abstract] [Full Text] [Related]
33. Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy.
Teng CF; Wu HC; Tsai HW; Shiah HS; Huang W; Su IJ
Hepatology; 2011 Oct; 54(4):1199-207. PubMed ID: 21735472
[TBL] [Abstract][Full Text] [Related]
34. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway.
Guo H; Zhou T; Jiang D; Cuconati A; Xiao GH; Block TM; Guo JT
J Virol; 2007 Sep; 81(18):10072-80. PubMed ID: 17609269
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
37. Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.
Melis M; Diaz G; Kleiner DE; Zamboni F; Kabat J; Lai J; Mogavero G; Tice A; Engle RE; Becker S; Brown CR; Hanson JC; Rodriguez-Canales J; Emmert-Buck M; Govindarajan S; Kew M; Farci P
J Transl Med; 2014 Aug; 12():230. PubMed ID: 25141867
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
[TBL] [Abstract][Full Text] [Related]
39. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
